PF-04531083 is used in pharmacological research to study the effects on the CB2 type cannabinoid receptor, which is involved in inflammation and pain. These studies aim to develop new drugs that can treat diseases related to chronic inflammation or neurological disorders. Additionally, it is used to test efficacy and safety in animal models before clinical trials in humans.